About Scipio Bioscience
Scipio Bioscience is a company based in Paris (France) founded in 2017 by Pierre Walrafen and Stuart Edelstein. Scipio Bioscience has raised $7.9 million across 3 funding rounds from investors including Financiere Arbevel, EIC Fund and M-Ventures. Scipio Bioscience operates in a competitive market with competitors including Abcam, GenScript, Sino Biological, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Paris, France
- Founders Pierre Walrafen, Stuart Edelstein
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.9 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Financiere Arbevel
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Scipio Bioscience
Unlock access to complete
Unlock access to complete
Board Team
6 people
Software Development Team
1 people
Sales and Marketing
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Scipio Bioscience
Scipio Bioscience has successfully raised a total of $7.9M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Scipio Bioscience
Scipio Bioscience has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Financiere Arbevel, EIC Fund and M-Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Venture capital firm investing in multiple sectors
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Locked | Locked | Locked |
Investor details for Scipio Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scipio Bioscience
Investment portfolio details for Scipio Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scipio Bioscience
Detailed financials for Scipio Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scipio Bioscience Comparisons
Peer comparison for Scipio Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scipio Bioscience
Scipio Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, GenScript, Sino Biological, Stem Cell Technologies and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of Scipio Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scipio Bioscience
Complete news archive for Scipio Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scipio Bioscience
Scipio Bioscience was founded in 2017.
Scipio Bioscience is headquartered in Paris, France.
Pierre Walrafen is the current CEO of Scipio Bioscience. They have also founded this company.
Scipio Bioscience is a funded company, having raised a total of $7.9M across 3 funding rounds to date.
Scipio Bioscience was founded in 2017 and is based in Paris, France. Operations focus on the bioscience sector, where benchtop kits for sample preparation in single-cell applications are developed. These kits support sequencing workflows, particularly transcriptomics, for use in clinical research and basic studies. The company addresses needs in research settings through specialized tools for cellular analysis.
Scipio Bioscience's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Scipio Bioscience has 6 investors. Key investors include Financiere Arbevel, EIC Fund, M-Ventures, Seventure Partners, and High-Tech Gründerfonds.